| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |